搜索到 1000 条关于 77c문발카지노디비상담♣텔레DaisoDBlㄱ 的文章
-
-
2016.06.15 肺癌患者的转折—肺癌诊治水平的飞跃
「就诊 77 次才查出肺癌」,百般寻医方确诊肺癌的新闻近日又给中国医疗敲响了警钟。能否早期做出诊断,对于癌症患者而言,常常就是生死一线之隔的区别。如何才能减少此类悲剧?医生如何才能全面、准确地判断患者的病情?如何才能直接有效地评估肿瘤发生发展的状态?如何才能定性定量地评定治疗的疗效?如何才能在术后专业监测复发
-
-
2019.03.15 容易误诊为出血的病变, 你 get 了吗?
病例 1,简要病史如下:患者,女性,77 岁,突发言语不能办饮水呛咳、吞咽困难 6 小时余。病史:患者 6 小时余前无明显诱因出血言语不能伴饮水呛咳、吞咽困难,交流障碍,无肢体活动感觉障碍,无意识不清、肢体抽搐、无耳鸣耳聋等。高血压病史 10 余年。既往脑梗死病史。病例 2,简要病史如下:患者,男性,48 岁
-
-
2017.06.14 ADA 2017:糖尿病过度治疗和个性化诊疗
第 77 届美国糖尿病协会(ADA)于 2017 年 6 月 9 日至 6 月 13 日在美国圣地亚哥召开,与会期间,世界各国的顶级糖尿病专家汇聚一堂,围绕糖尿病过度治疗和个性化治疗等主题展开研究和探讨,下面请看丁香园带来的相关主题速报。好事过头,反成坏事——过度治疗对糖尿病患者带来的后果来自顶级医疗机构美国梅奥诊所
-
-
2017.05.15 全球领先医疗科技/创新产品首发云集 CMEF 上海会
上将会找到答案。CMEF 医博会|ICMD 医疗器械制造展——「第 77 届中国国际医疗器械(春季)博览会(CMEF Spring 2017)暨第 24 届中国国际
-
-
2017.09.27 活久见!这里的肿瘤会议,有学术还有歌舞…
鹭江厅等你来!最后,想告诉你的是,CSCO 期间丁香园也来到了会场~我们的展台在 C2 展厅 B65,欢迎来展台逛逛,参加小活动就能赢取丁香园定制小礼物哦~
-
-
2016.08.27 ESC2016:血脂异常管理 哪些才是目标?
血脂管理是心血管疾病治疗的重要手段之一。总胆固醇(TC)、高密度脂蛋白(HDL-c)、低密度脂蛋白(LDL-c)和甘油三酯(TG)是临床上常用的血脂检查指标...意大利的Luigina GUASTI 教授在 ESC 2016 上带来她的建议。图 1 会场图片LDL-c :不同风险级别患者有不同目标水平血脂管理的
-
-
2013.09.10 创新中国2012
第七届创新中国DEMOCHINA2012自2月15日启动以来,征集了来自互联网、移动互联网、云计算、医疗健康、清洁技术、消费服务、文化创意等领域1000多个项目报名,有206家新创企业先后登上12个城市的分赛海选及软件和时尚2个专场的舞台,展示他们的创新产品技术和模式。总决赛上,77家晋级企业通过6
-
-
2015.11.27 Spine J:颈椎椎动脉横突段走行新知见
椎动脉为锁骨下动脉的第一个分支,在软组织内走行后,经 C6 横突孔,向上走行于颈椎 6 个横突孔内,出 C2 后,于 C2 和 C1 间构成一宽环。进入硬脑膜...风险在于易损伤椎动脉,特别是老年人后柱变薄、骨重建所致的椎动脉弯曲、扩张。土耳其近东大学的学者进行了一项回顾性横断面研究,表明 65 岁以上患者 C6 和 C
-
-
2017.05.23 立足「心声」平台,持续超声突破
2017 年 5 月 15 日,第 77 届中国国际医疗器械(春季)博览会在上海盛大开幕。GE医疗携 17 款业界领先的创新产品和数字化解决方案亮相。GE医疗全球临床护理解决方案总裁兼首席执行官 Anders Wold 和GE医疗中国超声事业部总经理马海燕先生重点展示了以 Vivid E95 为代表的「智尊」系列心脏
-
-
2017.05.16 新维度 观微界—— 生物梅里埃携新一代微生物实验室解决方案登陆 CMEF
中国上海,2017 年 5 月 15 日——全球领先的诊断企业,临床微生物检测行业领导者生物梅里埃公司携中国首个微生物领域全套整体解决方案惊艳亮相第 77 届中国国际医疗器械博览会(CMEF),系列展品涵盖检验平台、细菌培养系统、质谱监测系统等多个领域,为当前微生物检测领域提供产品线较全、技术领先且难以替代的顶级
-
-
2017.08.09 陆菊明教授:二甲双胍是 T2DM 患者降糖首选
后和空腹血糖,且使 HbA1c 明显下降。早在 1995 年美国的 DeFronzo 教授的经典研究比较了二甲双胍单药和安慰剂对于 2 型糖尿病患者的疗效。研究证实二甲双胍组 HbA1c 降低了 1.4%,而安慰剂组则升高 0.4%。同时也观察到,相比安慰剂组,二甲双胍可以显著降低空腹血糖和餐后血糖,此后二甲双胍在临床的使用
-
-
2016.04.28 高密度脂蛋白水平与肾脏病结局呈 U 型曲线关系
既往有研究报道高密度脂蛋白胆固醇(HDL-C)的缺乏或功能紊乱与肾脏血管粥样硬化、肾小球肾炎及肾小管间质损伤等有关,虽然越来越多的研究认为低水平 HDL-C 与发生肾脏病风险相关,HDL-C 在慢性肾脏病(CKD)进展中的作用越来越明显,但是 HDL-C 与肾脏病结局(CKD 危险因素及 CKD 进展危险因素)尚未
-
-
2014.02.10 LDR首获FDA关于双节段颈椎间盘置换批准
基于主要终点分析,Mobi-C®颈椎间盘在双节段应用中相比融合术对照治疗显示出统计学优势德克萨斯州奥斯汀(2013年8月28...局(FDA)颁发的批准函,允许商业销售及分销Mobi-C颈椎间盘(Mobi-C)用于双节段相关适应症,使其成为全美首个也是唯一一个获准用于治疗单个
-
-
2012.04.13 依折麦布/辛伐他汀在抑制胆固醇吸收减少原发性高胆固醇血症发病率优于辛伐他汀
Hypercholesterolemia摘要:通过为期12周的试验,探讨不同剂量的依折麦布/辛伐他汀与辛伐他汀对患者LDL-C及其它脂蛋白的影响。结果显示依折麦布/辛伐他汀的血脂调整效果较单用辛伐他汀更佳。研究设计样本情况与单一使用辛伐他汀比较依折麦布/辛伐他汀组LDL-C水平
-
2013.12.11 T2DM患者使用非诺贝特应谨慎
研究要点:同时接受非诺贝特和噻唑烷二酮类(TZD)治疗的T2DM患者,HDL-C水平显著降低极低HDL-C的发生可能与非诺贝特和TZD同时使用有关为了测定控制糖尿病心血管疾病风险行动(ACCORD)脂质试验中参与者极低HDL-C的发生情况,并对极低HDL-C
-
2012.09.19 16th Congress of the Asian Pacific Society of Respirology


16th Congress of the Asian Pacific Society of Respirology
3 – 6 November, 2011, Shanghai
www.apsr2011.orgWelcome message from the Honorary Congress PresidentOn behalf of the Local Congress Committee, it is my honor to cordially invite you all to the 16th APSR. In its 16th year, the APSR Congress has been welcomed for the third time to China and we consider it a great honor to host this event, for the first time in Shanghai. The Congress venue will be the Shanghai International Convention Center. The APSR, Chinese Society of Respiratory Diseases and Shanghai Medical Association have joined forces as co-organizers of the Congress to bring together physicians, academics, healthcare professionals and decision makers in the field of respiratory medicine from around the world to discuss emerging issues and exchange ideas on current research and clinical topics in respirology.The Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in respirology, primarily in conditions commonly found in the Asia Pacific region. The meeting will invite many distinguished international speakers who are expected to participate and provide insights and expert opinion on a wide range of topics in pulmonary and respiratory medicine.I hope that you will enjoy the Congress and that your interaction with your colleagues from different countries will stimulate a creative exchange of ideas and will be personally rewarding. I also trust that you will enjoy your visit to the beautiful and exciting city of Shanghai, in November 2011.

Prof. Zhong Nanshan
Honorary Congress President, APSR 2011
Welcome message from the Congress PresidentIt is my great pleasure and honor as Congress President, to welcome you to the 16th Congress of the Asian Pacific Society of Respirology (APSR). The APSR is renowned as a dynamic organization showcasing the breadth and depth of respiratory medicine across the Asia Pacific region. Following the success of the two previous meetings held in China, this year’s congress hosted by Chinese Society of Respiratory Diseases (CSRD) and Shanghai Medical Association, will be held at the Shanghai International Convention Center, in the vibrant and international metropolis of Shanghai. Since its inception and first meeting held in Tokyo in 1988, the congress has gone from strength to strength and we are expecting this year’s meeting to be no exception and continue this momentum to be an outstanding success.Scheduled for the 3 – 6 November 2011, this four-day congress will feature a comprehensive scientific program, including post-graduate courses, lectures and symposia conducted by key note speakers, who are experts in the field of respirology. In addition, oral and poster presentations will provide exposure for researchers, as a platform for academic exchange on exciting new topics currently under investigation. The organizing committee has organized a range of social events and tours to encourage participants to experience the diverse local culture and traditions of the host city.I hope this Congress will be an exciting and productive gathering of respirologists from the Asia Pacific Region and provide an opportunity to share their knowledge, experience and views on current respiratory disease topics, and provide a platform for networking and collaboration between academics and physicians across the region.I would like to thank the APSR 2011 Local Congress Committee for their dedication and support in making this Congress a success and I would also like to thank all participants for their continued interest and involvement in these meetings and look forward to meeting you in November in Shanghai.We invite you to visit the website (www.apsr2011.org) regularly for the latest updates and news about the organization of the Congress.See you in Shanghai in 2011

Prof. Bai Chunxue
Congress President, APSR 2011
-
-
2014.07.28 升高HDL胆固醇类药物并没有实际治疗收益
在血脂调控领域始终有一个缺乏说服力的假设——贝特类、烟酸和胆甾醇酯转运蛋白(CETP)阻滞剂等药物可以通过升高HDL胆固醇(HDL-C)水平达到降低患者心血管疾病(CV)事件的作用。但是近期一项由Matthew Shun-Shin博士带领开展的meta分析却再次向这种假设提出了质疑,他们发现这些升HDL-C药物并不能
